Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development
G. Wirjanata, J. Lin, J. Dziekan, A. El Sahili, Z. Chung, S. Tjia, N. E. B. Zulkifli, J. Boentoro, R. Tham, S. J. Lai, K. Go, Y. Han, A. Partridge, D. Olsen, N. Prabhu, , Z. Bozdech
This study identifies falcilysin as a target of anti-malaria drugs and reveals a shared inhibitory pocket that could guide new drug development.
bioRxiv · Apr 8, 2021Microbiology